Opioid use disorder

14,834views

Opioid use disorder

Patho

Patho

Cardiovascular system anatomy and physiology
Normal heart sounds
Abnormal heart sounds
Blood pressure, blood flow, and resistance
Measuring cardiac output (Fick principle)
Pressures in the cardiovascular system
Baroreceptors
Chemoreceptors
Renin-angiotensin-aldosterone system
Cardiac contractility
Cardiac conduction system
Myocardial infarction
Angina pectoris
Aortic dissection
Aneurysms
Tricuspid valve disease
Mitral valve disease
Pulmonary valve disease
Aortic valve disease
Hypertrophic cardiomyopathy
Skin anatomy and physiology
Wound healing
Hair, skin and nails
Atopic dermatitis
Psoriasis
Lichen planus
Vitiligo
Albinism
Burns
Actinic keratosis
Skin cancer
Endocrine system anatomy and physiology
Thyroid hormones
Cortisol
Synthesis of adrenocortical hormones
Calcitonin
Parathyroid hormone
Vitamin D
Cushing syndrome
Diabetes mellitus
Hyperparathyroidism
Hypoparathyroidism
Hypothyroidism
Hyperthyroidism
Toxic multinodular goiter
Graves disease
Thyroid cancer
Pheochromocytoma
Neuroblastoma
Gastrointestinal system anatomy and physiology
Pancreatic secretion
Liver anatomy and physiology
Bile secretion and enterohepatic circulation
Carbohydrates and sugars
Proteins
Fats and lipids
Prebiotics and probiotics
Vitamins and minerals
Barrett esophagus
Gastroesophageal reflux disease (GERD)
Peptic ulcer
Colorectal polyps
Crohn disease
Ulcerative colitis
Gallstones
Cirrhosis
Non-alcoholic fatty liver disease
Alcohol-associated liver disease
Hemochromatosis
Viral hepatitis
Portal hypertension
Hirschsprung disease
Pyloric stenosis
Oral cancer
Benign liver tumors
Blood components
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Platelet plug formation (primary hemostasis)
Role of Vitamin K in coagulation
Iron deficiency anemia
Alpha-thalassemia
Beta-thalassemia
Anemia of chronic disease
Aplastic anemia
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Von Willebrand disease
Hemophilia
Acute leukemia
Chronic leukemia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Skeletal system anatomy and physiology
Cartilage structure and growth
Bone remodeling and repair
Fibrous, cartilage, and synovial joints
Rheumatoid arthritis
Gout
Systemic lupus erythematosus
Raynaud phenomenon
Amyloidosis
Scleroderma
Fibromyalgia
Osteoarthritis
Paget disease of bone
Osteoporosis
Legg-Calve-Perthes disease
Osteomalacia and rickets
Osgood-Schlatter disease (traction apophysitis)
Septic arthritis
Osteomyelitis
Lordosis, kyphosis, and scoliosis
Rotator cuff tear
Meniscus tear
Sprained ankle
Compartment syndrome
Bone tumors
Developmental dysplasia of the hip
Nervous system anatomy and physiology
Anatomy and physiology of the eye
Anatomy and physiology of the ear
Neuron action potential
Sympathetic nervous system
Parasympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Cerebellum
Optic pathways and visual fields
Cranial nerves
Brachial plexus
Seizures and epilepsy
Migraine
Alzheimer disease
Frontotemporal dementia
Vascular dementia
Dementia with Lewy bodies
Multiple sclerosis
Muscular dystrophy
Bell palsy
Concussion and traumatic brain injury
Cauda equina syndrome
Neurogenic bladder
Parkinson disease
Sciatica
Carpal tunnel syndrome
Eustachian tube dysfunction
Glaucoma
Major depressive disorder
Major depressive disorder with seasonal pattern
Suicide
Bipolar and related disorders
Generalized anxiety disorder
Post-traumatic stress disorder
Schizophrenia
Alcohol use disorder
Tobacco use disorder
Cannabis use disorder
Opioid use disorder
Cocaine use disorder
Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Autism spectrum disorder
Attention deficit hyperactivity disorder
Learning disability
Delirium
Renal system anatomy and physiology
Movement of water between body compartments
Renal clearance
Osmoregulation
Antidiuretic hormone
Regulation of renal blood flow
Glomerular filtration
Proximal convoluted tubule
Loop of Henle
Potassium homeostasis
Phosphate, calcium and magnesium homeostasis
Sodium homeostasis
The role of the kidney in acid-base balance
Diabetic nephropathy
Lower urinary tract infection
Acute pyelonephritis
Chronic pyelonephritis
Kidney stones
Urinary incontinence
Hydronephrosis
Polycystic kidney disease
Estrogen and progesterone
Menstrual cycle
Menopause
Oxytocin and prolactin
Pregnancy
Anatomy and physiology of the female reproductive system
Anatomy and physiology of the male reproductive system
Testosterone
Development of the reproductive system
Puberty and Tanner staging
Ovarian cyst
Endometriosis
Uterine fibroid
Endometritis
Amenorrhea
Benign prostatic hyperplasia
Pelvic inflammatory disease
Cervical cancer
Endometrial cancer
Breast cancer
Respiratory system anatomy and physiology
Respiratory syncytial virus
Pneumonia
Asthma
Chronic bronchitis
Emphysema
Nasal polyps
Sinusitis
Bacterial epiglottitis
Allergic rhinitis
Upper respiratory tract infection
Laryngitis
Retropharyngeal and peritonsillar abscesses
Pulmonary hypertension
Lung cancer
Mesothelioma
Sleep apnea
Restrictive lung diseases

Transcript

Watch video only

Worldwide, opioids are the most common cause of drug-related deaths.
The number of individuals using opioids has drastically increased over time, with an uptick in heroin use, and an even bigger uptick in prescription opioid use, and a large number of people using both. Because of the potential for opioid use disorder and overdose, opioids are regulated substances in many countries.

As a class, opioids share one thing in common—they bind to opioid receptors in the brain, spinal cord, and gastrointestinal tract. Some are endogenous, meaning that they are produced naturally by the body, like endorphins, which are named for “endogenous morphine” due to their similar effects on the body. But others are exogenous, meaning that they come from outside the body, like heroin and morphine, which come from the opium poppy—a flowering plant that oozes a milky white liquid—while others like fentanyl are synthesized in the laboratory.

To understand how opioids work, let’s zoom in on a region of the spinal cord that has opioid receptors. Normally, in the absence of endorphins, nociceptive fibers carry pain signals from the body to the dorsal, or posterior, horn of the spinal cord.

Here they release neurotransmitters,

like glutamate, substance P and calcitonin gene-related peptide. These neurotransmitters cause pain signals to be transmitted to the brain via ascending pain pathways.

Now, let’s say someone goes to play a rigorous game of badminton. Exercise releases endorphins which activate the three major opioid receptors located on neurons, called the mu, kappa, and delta receptors.

As endorphins or other opioids bind to these receptors on the presynaptic terminals of nociceptive fibers, they inhibit the opening of calcium channels, preventing calcium influx, and thereby blocking the release of pain-causing neurotransmitters like glutamate, substance P and calcitonin gene-related peptide. At the same time, endorphins also bind to postsynaptic neurons, opening potassium channels here, leading to hyperpolarization and decreased excitability of the neuron. These effects together reduce the transmission of pain signals to the brain.

If we move up to the brain’s reward pathway, made up of midbrain regions like the ventral tegmental area, nucleus accumbens, and prefrontal cortex, we find another important effect of opioids.

Here, inhibitory neurons normally release gamma-aminobutyric acid, or GABA, at the presynaptic terminal, which in turn inhibits postsynaptic dopaminergic neurons, leading to decreased dopamine release.

But, when there are endorphins or opioids in the area, they bind to the opioid receptors on these inhibitory GABAergic neurons, causing a decrease in GABA release. With less GABA around, there is less inhibition of dopaminergic neurons, leading to a flood of dopamine in the brain’s reward center. This increased dopamine leads to a calming sensation and feelings of pleasure or euphoria, also known as an emotional “high”.

Now remember, the purpose of the reward pathway is to train the brain to repeat activities that cause dopamine-mediated pleasure, so when opioids stimulate this reward pathway, the brain learns to do that behavior again and again.

With exogenous opioids, there are multiple routes to get the drug to the brain.

One way is by ingesting it; that route is the slowest. A faster route would be inhalation because the drug is rapidly absorbed through the lungs; this route is not routinely used medically and is more commonly encountered with substance misuse.

The fastest route is direct injection of the substance into the blood. Typically, the faster the exogenous opioid reaches the brain, the stronger the relationship between the behavior and the reward.

Over time, people can develop tolerance to a drug. Tolerance means that with repeated use, their response to the drug decreases. As a result, even when taking the medication exactly as prescribed, a higher dose may be needed to achieve the same effect as before.

At a cellular level, there are two main reasons for why this happens.

One reason is that opioid receptors become less sensitive to stimulation by a drug, and the other reason is that the neurons may remove opioid receptors from the cell membrane in a process called down-regulation, leaving fewer receptors available for binding. In either scenario, tolerance leads to the need for higher and higher doses of a drug, and often that tolerance remains for a long time even after tapering off the drug.

Alright, so now let’s say that you’re at rest, there aren’t any drugs or anything else stimulating your reward pathway. In this situation, your brain keeps your heart rate, blood pressure, and wakefulness in a normal state, called homeostasis.

Now, let’s say you finally get a text with exam results that you’ve been waiting weeks for. All of a sudden you may feel sweaty and flushed, your heart rate may jump a bit. You’re now above your normal level of homeostasis, because something has changed, right? But it doesn’t stay that way for long, and after the text message, your brain brings things back down to this baseline.

With repeated drug use, a few things start to happen.
Let’s say you take a drug at a specific time and setting, like 3:00 P.M. in the bedroom, every day.

If it’s a depressant, it makes everything go lower: heart rate, blood pressure, and wakefulness.

Your brain, being the smart brain that it is, will pick up on this pattern.

So, the next time it’s 3:00 P.M. in the bedroom, your brain preemptively increases heart rate, blood pressure and wakefulness, since it knows that when you take the drug, everything’s going to decrease again.

Now, let’s say 3:00 P.M. in the bedroom rolls around, but there’s no drug…

In that situation, the brain still increases everything, but the changes aren’t countered with the effects of the drug, and so the person can feel awful;

these are called withdrawal symptoms. These symptoms can persist to the point where a person may need drugs just to feel normal, and if that’s the case, they are considered to be dependent on that drug.

Now, on the flipside, let’s say that you use the drug in an unfamiliar setting, like at 11:00 P.M. at a party. Well in that situation, your body’s not ready for the drug and there’s no physiologic “counterbalance” to help offset the effect of the drug.

When that happens, it can lead to overdose, even on a “normal” dose that the person’s taking, and that’s oftentimes what happens.

The symptoms of opioid withdrawal include dysphoric mood, myalgias, sweating and shivering, yawning, nausea, vomiting, and diarrhea, rhinorrhea, pupillary dilation, and insomnia.

These symptoms can feel really awful, and often prompt people to use opioids again. This is called negative reinforcement, since you’re removing the drug, which causes withdrawal symptoms which reinforces more drug use to avoid those symptoms.

Key Takeaways

An opioid use disorder is a medical condition that is characterized by the compulsive use of opioids in spite of adverse consequences from continued use and the development of a withdrawal syndrome when opioid use stops. Opioids include substances such as morphine, heroin, codeine, oxycodone, hydrocodone, etc. The necessary descriptive characteristics of the medical diagnosis are preoccupation with a desire to obtain and take the drug and persistent drug-seeking behaviour. 

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine" McGraw Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Pharmacological therapies for management of opium withdrawal" Cochrane Database of Systematic Reviews (2018)
  5. "An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program" Drug and Alcohol Dependence (2011)
  6. "Cellular basis of memory for addiction" Dialogues in Clinical Neuroscience (2013)